Landscape Capital Management, L.L.C. Intellia Therapeutics, Inc. Transaction History

Landscape Capital Management, L.L.C.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$23.16 - $32.34 $261,684 - $365,409	11,299 New	11,299 $344,000
Q3 2021 Nov 09, 2021	SELL	$132.37 - $176.78 $429,937 - $574,181	-3,248 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$60.88 - $161.91 $197,738 - $525,883	3,248 New	3,248 $526,000
Q1 2018 May 11, 2018	SELL	$19.43 - $34.95 $901,318 - $1.62 Million	-46,388 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$17.39 - $31.12 $649,499 - $1.16 Million	37,349 Added 413.2%	46,388 $892,000
Q3 2017 Nov 14, 2017	SELL	$15.16 - $25.75 $406,712 - $690,821	-26,828 Reduced 74.8%	9,039 $225,000
Q2 2017 Aug 14, 2017	BUY	N/A	35,867	35,867 $574,000

336

96.1M

1.06M

863K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $707M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.